Wells Fargo & Company Third Harmonic Bio, Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 6,861 shares of THRD stock, worth $80,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,861
Previous 5,976 14.81%
Holding current value
$80,342
Previous $65,000 1.54%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$8.6 - $11.24 $7,611 - $9,947
885 Added 14.81%
6,861 $64,000
Q4 2023

Feb 09, 2024
BUY
$5.97 - $11.47 $7,062 - $13,569
1,183 Added 24.68%
5,976 $65,000
Q3 2023

Nov 13, 2023
SELL
$4.92 - $7.09 $12,644 - $18,221
-2,570 Reduced 34.9%
4,793 $30,000
Q2 2023

Aug 15, 2023
BUY
$4.18 - $5.33 $21,075 - $26,873
5,042 Added 217.23%
7,363 $35,000
Q1 2023

May 12, 2023
BUY
$3.95 - $4.49 $9,167 - $10,421
2,321 New
2,321 $9,000

Others Institutions Holding THRD

# of Institutions
68
Shares Held
35.8M
Call Options Held
0
Put Options Held
0
View Full List

About Third Harmonic Bio, Inc.

THRD Quotes by TradingView
  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $472M
More about THRD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email